Sunday, April 12, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Oracle’s Restructuring Gamble: Can Cost Cuts Fuel a $50 Billion AI Dream?

SiterGedge by SiterGedge
April 12, 2026
in AI & Quantum Computing, Analysis, Earnings, Nasdaq, Tech & Software
0
Oracle Stock
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Oracle’s aggressive push into artificial intelligence is creating a stark financial dichotomy. While the company unveils ambitious new products and secures record future contracts, the cost of this transformation is triggering analyst downgrades and one of the most significant workforce reductions in its history. The software giant is attempting to finance a monumental technological shift through drastic internal restructuring, a high-wire act that is dividing Wall Street.

The scale of Oracle’s ambition was on full display recently at a New York event, where it introduced 22 new AI-driven “Fusion Agentic Applications” designed to automate workflows in finance and human resources. This product offensive underscores a strategic pivot, but the financial foundations are straining. To build out the necessary AI data center infrastructure, Oracle anticipates capital expenditures reaching a staggering $50 billion in its 2026 fiscal year.

Funding this expansion has necessitated extreme measures. The company is in the process of eliminating an estimated 30,000 positions globally, representing approximately 18 percent of its total workforce. Analysts at TD Cowen calculate this restructuring could unlock between $8 billion and $10 billion in annual free cash flow. These savings are urgently needed, as Oracle’s total debt has now surged past the $100 billion mark, making its balance sheet particularly sensitive to persistent high interest rates.

This tense financial backdrop directly influenced a key analyst move. Cleveland Research downgraded Oracle’s stock from “Buy” to “Neutral” on Friday, with analyst Ari Terjanian citing soaring costs for AI data centers and their pressure on cash flow. The stock has felt the weight of these concerns, declining nearly 29 percent since the start of the year and closing a recent session at 118.88 euros.

Should investors sell immediately? Or is it worth buying Oracle?

Yet, opposing this narrative of high costs is a story of explosive growth and unprecedented demand. Oracle’s third-quarter results for fiscal 2026 were robust, with total revenue climbing 22 percent to $17.2 billion and adjusted net income rising 23 percent to $5.2 billion. The cloud infrastructure business, the clear growth engine, skyrocketed 84 percent to $4.9 billion. Most strikingly, remaining performance obligations (RPO)—a measure of future contracted revenue—ballooned by 325 percent year-over-year to $553 billion, driven largely by long-term AI contracts.

This divergence in fundamentals has split analyst opinion. While Cleveland Research turned cautious, Evercore ISI reaffirmed its “Buy” rating with a $220 price target. The broader analyst consensus sits at “Moderate Buy,” with an average price target of $260.71, suggesting significant potential upside from current levels.

Steering the company through this period of simultaneous investment and austerity is a new financial leader. Hilary Maxson, formerly of Schneider Electric, assumed the CFO role on April 6. Her compensation package includes a base salary of $950,000 and equity awards valued at approximately $26 million, 80 percent of which vest over four years. Her immediate challenge is managing the massive $50 billion investment plan against a towering debt load.

Shareholders, meanwhile, can expect their regular quarterly dividend payment, with the payout date set for April 24 following an April 9 ex-dividend date. The next major financial update will come in June with the release of Oracle’s fourth-quarter results. Management has already provided earnings per share guidance for that period in a range of $1.96 to $2.00. The figures will offer a critical look at whether the company’s radical cost-cutting can sustainably power its even more radical AI expansion.

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from April 12 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 12.

Oracle: Buy or sell? Read more here...

Tags: Oracle
SiterGedge

SiterGedge

Related Posts

Refined Energy Stock
Analysis

Refined Energy’s Uranium Hunt Awaits Lab Verdict as Warrant Lock-Up Expires

April 12, 2026
Realty Income Stock
Dividends

Realty Income’s Dual Catalysts: Dividend Milestone Meets Q1 Earnings Test

April 12, 2026
ImmunityBio Stock
Analysis

ImmunityBio’s Record Revenue Meets Mounting Legal Pressure

April 11, 2026
Next Post
Ams Osram Stock

Ams Osram's Financial Reckoning Meets a High-Tech Bet

Refined Energy Stock

Refined Energy's Uranium Hunt Awaits Lab Verdict as Warrant Lock-Up Expires

Recommended

Hartford Services Stock

Hartford Financial Services Exceeds Market Expectations with Strong Q4 2025

2 months ago
Technology Cloud computing

Insider Trades of Palantir and Zoom Amazon and Emerson Electric Remain Undisclosed

2 years ago
Electronic Arts Stock

Electronic Arts Stock: Strong Releases Counterbalanced by Insider Activity

7 months ago
CRWD stock news

Entegris NASDAQ ENTG Receives Buy Recommendation and 150 Price Target from Needham Analyst

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Realty Income’s Dual Catalysts: Dividend Milestone Meets Q1 Earnings Test

ImmunityBio’s Record Revenue Meets Mounting Legal Pressure

Strategy’s Solitary Bitcoin Bet: A $14.5 Billion Paper Loss and Unwavering Conviction

BioNTech’s Oncology Drive Gains Momentum with Key Data and Analyst Backing

Shadow Banks, Record Defaults, and the $1.8 Trillion Fracture

Orora’s Strategic Pivot: Shifting Glass Production from the Middle East to Mexico

Trending

Refined Energy Stock
Analysis

Refined Energy’s Uranium Hunt Awaits Lab Verdict as Warrant Lock-Up Expires

by Kennethcix
April 12, 2026
0

The coming days will deliver crucial data points for investors in Refined Energy, with the uranium explorer...

Ams Osram Stock

Ams Osram’s Financial Reckoning Meets a High-Tech Bet

April 12, 2026
Oracle Stock

Oracle’s Restructuring Gamble: Can Cost Cuts Fuel a $50 Billion AI Dream?

April 12, 2026
Realty Income Stock

Realty Income’s Dual Catalysts: Dividend Milestone Meets Q1 Earnings Test

April 12, 2026
ImmunityBio Stock

ImmunityBio’s Record Revenue Meets Mounting Legal Pressure

April 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Refined Energy’s Uranium Hunt Awaits Lab Verdict as Warrant Lock-Up Expires
  • Ams Osram’s Financial Reckoning Meets a High-Tech Bet
  • Oracle’s Restructuring Gamble: Can Cost Cuts Fuel a $50 Billion AI Dream?

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com